{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:01:14Z","timestamp":1787839274936,"version":"build-2784847793"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The Lassa virus (LASV), an RNA virus prevalent in West and Central Africa, causes severe hemorrhagic fever with a high fatality rate. However, no FDA-approved treatments or vaccines exist. Two crucial proteins, LASV glycoprotein and nucleoprotein, play vital roles in pathogenesis and are potential therapeutic targets. As effective treatments for many emerging infections remain elusive, cutting-edge drug development approaches are essential, such as identifying molecular targets, screening lead molecules, and repurposing existing drugs. Bioinformatics and computational biology expedite drug discovery pipelines, using data science to identify targets, predict structures, and model interactions. These techniques also facilitate screening leads with optimal drug-like properties, reducing time, cost, and complexities associated with traditional drug development. Researchers have employed advanced computational drug design methods such as molecular docking, pharmacokinetics, drug-likeness, and molecular dynamics simulation to investigate evodiamine derivatives as potential LASV inhibitors. The results revealed remarkable binding affinities, with many outperforming standard compounds. Additionally, molecular active simulation data suggest stability when bound to target receptors. These promising findings indicate that evodiamine derivatives may offer superior pharmacokinetics and drug-likeness properties, serving as a valuable resource for professionals developing synthetic drugs to combat the Lassa virus.<\/jats:p>","DOI":"10.3389\/fmicb.2023.1206872","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T06:26:39Z","timestamp":1689056799000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents"],"prefix":"10.3389","volume":"14","author":[{"given":"Shopnil","family":"Akash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjat","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobendu","family":"Mukerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vetriselvan","family":"Subramaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rezaul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinibha","family":"Rajakumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh V.","family":"Chinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gobinath","family":"Ramachawolran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez M.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer M.","family":"Albadrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Abdel-Daim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/molecules27030903","article-title":"Potential antiviral action of alkaloids","volume":"27","author":"Abookleesh","year":"2022","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4269\/ajtmh.20-1160","article-title":"Years of lassa fever outbreaks in Nigeria, 1969-2020: an epidemiologic analysis of the temporal and spatial trends","volume":"105","author":"Agbonlahor","year":"2021","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/17425255.2017.1389897","article-title":"In silico ADME-Tox modeling: progress and prospects","volume":"13","author":"Alqahtani","year":"2017","journal-title":"Expert. Opinion. Drug. Metab. Toxicol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","article-title":"Clinical sequencing uncovers origins and evolution of Lassa virus","volume":"162","author":"Andersen","year":"2015","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.idc.2019.08.002","article-title":"Lassa fever: epidemiology, clinical features, diagnosis, management and prevention","volume":"33","author":"Asogun","year":"2019","journal-title":"Inf. Dis. Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2807\/ese.14.10.19145-en","article-title":"The first case of Lassa fever imported from Mali to the United Kingdom, February 2009","volume":"14","author":"Atkin","year":"2009","journal-title":"Eurosurveillance"},{"key":"B7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4314\/ajcem.v17i4.9","article-title":"Review of Lassa fever, an emerging old world haemorrhagic viral disease in sub-Saharan Africa","volume":"17","author":"Azeez-Akande","year":"2016","journal-title":"Afr. J. Clin. Exp. Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J. Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-63640-1","article-title":"In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever","volume":"10","author":"Baral","year":"2020","journal-title":"Sci. Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1934578X","DOI":"10.1177\/1934578X221143082","article-title":"Toward the discovery of SARS-CoV-2 main protease inhibitors: exploring therapeutic potentials of evodiamine and its derivatives, virtual screening, molecular docking, and molecular dynamic studies","volume":"17","author":"Belal","year":"2022","journal-title":"Nat. Prod. Commun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00090","DOI":"10.1128\/JVI.00090-19","article-title":"Differential antibody-based immune response against isolated GP1 receptor-binding domains from Lassa and Junin viruses","volume":"93","author":"Borenstein-Katz","year":"2019","journal-title":"J. Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","article-title":"Genetic diversity among Lassa virus strains","volume":"74","author":"Bowen","year":"2000","journal-title":"J. Virol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B14","unstructured":"Lassa. Fever2022"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042706","author":"Dai","year":"2012","journal-title":"A drug screening method based on the autophagy pathway and studies of the mechanism of evodiamine against influenza A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"2","author":"Dallakyan","year":"2015","journal-title":"Chem. Biol. Methods. Prot"},{"key":"B18","author":"Design","year":"2014"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"B21","doi-asserted-by":"publisher","first-page":"105154","DOI":"10.1016\/j.bioorg.2021.105154","article-title":"Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma","volume":"114","author":"Fan","year":"2021","journal-title":"Bioorg. Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin. Pharm. Therap"},{"key":"B23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.fitote.2015.07.019","article-title":"Therapeutic and cosmetic applications of Evodiamine and its derivatives\u2014A patent review","volume":"106","author":"Gavaraskar","year":"2015","journal-title":"Fitoterapia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"13793","DOI":"10.1128\/JVI.78.24.13793-13803.2004","article-title":"Replicon system for Lassa virus","volume":"78","author":"Hass","year":"2004","journal-title":"J. Virol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"J. l\/lolec","volume":"14","author":"Humphrey","year":"","journal-title":"J. Mol. Graphics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"","journal-title":"J. Mol. Graph"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19967","DOI":"10.1073\/pnas.1108910108","article-title":"X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation","volume":"108","author":"Igonet","year":"2011","journal-title":"Proc. Nat. Acad. Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/1574893615666191219094216","article-title":"Relevance of molecular docking studies in drug designing","volume":"15","author":"Jakhar","year":"2020","journal-title":"Curr. Bioinf"},{"key":"B29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bib\/2.2.195","article-title":"Swiss-PDB viewer (deep view)","volume":"2","author":"Kaplan","year":"2001","journal-title":"Briefings. Bioinf"},{"key":"B30","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical","volume":"47","author":"Kim","year":"2019","journal-title":"Data"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12701","DOI":"10.1073\/pnas.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P","volume":"98","author":"Lenz","year":"2001","journal-title":"Proc. Nat. Acad. Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1005418","DOI":"10.1371\/journal.ppat.1005418","article-title":"Acidic pH-induced conformations and LAMP1 binding of the Lassa virus glycoprotein spike","volume":"12","author":"Li","year":"2016","journal-title":"PLoS. Pathog"},{"key":"B33","doi-asserted-by":"publisher","first-page":"153180","DOI":"10.1016\/j.phymed.2020.153180","article-title":"Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases","volume":"68","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"113960","DOI":"10.1016\/j.ejmech.2022.114530","article-title":"Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer","volume":"228","author":"Liang","year":"2022","journal-title":"Eur. J. Med. Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug. Discovery. Today. Technol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J. Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"12696","DOI":"10.1128\/JVI.00882-07","article-title":"Differential inhibition of type I interferon induction by arenavirus nucleoproteins","volume":"81","author":"Mart-nez-Sobrido","year":"2007","journal-title":"J. Virol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9192","DOI":"10.1128\/JVI.00555-06","article-title":"Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus","volume":"80","author":"Mart-nez-Sobrido","year":"2006","journal-title":"J. Virol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-642-56029-3_4","article-title":"Lassa fever","volume":"4","author":"McCormick","year":"2002","journal-title":"Arenaviruses I: the Epidemiology. Mol. Cell. Biol. Arenaviruses"},{"key":"B40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-642-56029-3_6","article-title":"Arenaviruses: genomic RNAs, transcription, and replication","volume":"2","author":"Meyer","year":"2002","journal-title":"Mol. Cell. Biol. Arenaviruses"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.corsci.2015.01.037","article-title":"Density functional theory (DFT) as a powerful tool for designing new organic corrosion inhibitors. Part 1: an overview","volume":"99","author":"Obot","year":"2015","journal-title":"Corrosion. Sci"},{"key":"B42","first-page":"1","article-title":"Lassa fever in West African sub-region: an overview","volume":"44","author":"Ogbu","year":"2007","journal-title":"J. Vector. Borne. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1021\/ct900566x","article-title":"Efficient diffuse basis sets for density functional theory","volume":"6","author":"Papajak","year":"2010","journal-title":"J. Chem. Theor. Comput"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s11095-013-1119-z","article-title":"Methodologies to assess drug permeation through the blood\u2013brain barrier for pharmaceutical research","volume":"30","author":"Passeleu-Le Bourdonnec","year":"2013","journal-title":"Pharm. Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nature09605","article-title":"Cap binding and immune evasion revealed by Lassa nucleoprotein structure","volume":"468","author":"Qi","year":"2010","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3329\/ijpls.v1i2.12955","article-title":"Use of computer in drug design and drug discovery: a review","volume":"1","author":"Rahman","year":"2012","journal-title":"Int. J. Pharm. Life. Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jmmm.2015.04.091","article-title":"Density functional theory applied to magnetic materials: Mn3O4 at different hybrid functionals","volume":"391","author":"Ribeiro","year":"2015","journal-title":"J. Mag. Magnet. Mat"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1128\/JVI.00560-08","article-title":"Different mechanisms of cell entry by human-pathogenic old world and new world arenaviruses","volume":"82","author":"Rojek","year":"2008","journal-title":"J. Virol"},{"key":"B50","article-title":"The RCSB protein data bank: integrative view of protein, gene and 3D structural information","author":"Rose","year":"2016","journal-title":"Nucleic. Acids. Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/ptr.5359","article-title":"In vitro assessment of the anticancer potential of evodiamine in human oral cancer cell lines","volume":"29","author":"Sachita","year":"2015","journal-title":"Phytotherapy. Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell. Biol. Toxicol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/B978-0-12-816954-4.00007-3","article-title":"Applications of BIOVIA materials studio, LAMMPS, and GROMACS in various fields of science and engineering","volume":"5","author":"Sharma","year":"2019","journal-title":"Mol. Dyn. Simulation. Nanocomp. BIOVIA. Mat. Studio. Lammps. Gromacs"},{"key":"B54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-981-15-6815-2_7","article-title":"Molecular dynamics simulation of protein and protein\u2013ligand complexes","volume":"5","author":"Shukla","year":"2020","journal-title":"Comput. Aided. Drug. Design"},{"key":"B55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-3-319-41342-6_14","article-title":"Evodiamine and its role in chronic diseases","volume":"5","author":"Tan","year":"2016","journal-title":"Drug. Discovery. Mother. Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.14202\/IJOH.2020.95-98","article-title":"Lassa fever: history, causes, effects, and reduction strategies","volume":"2","author":"Tewogbola","year":"2020","journal-title":"Virus"},{"key":"B57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem"},{"key":"B58","unstructured":"Nigeria. records. 189. Lassa. Fever. Deaths. \u2014. NCDC2023"},{"key":"B59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11571-017-9471-z","article-title":"Protective effects of evodiamine in experimental paradigm of Alzheimer's disease","volume":"12","author":"Wang","year":"2018","journal-title":"Cognitive. Neurodyn"},{"key":"B60","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1210\/en.2007-0467","article-title":"Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated kinase\/mitogen-activated protein kinase signaling","volume":"149","author":"Wang","year":"2008","journal-title":"Endocrinology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijbs.8.1","article-title":"Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K\/Akt pathway","volume":"8","author":"Wei","year":"2012","journal-title":"Int. J. Biol. Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3892\/ijmm.2015.2383","article-title":"Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells","volume":"36","author":"Wen","year":"2015","journal-title":"Int. J. Mol. Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2017.02.017","article-title":"Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma","volume":"485","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/molecules22060943","article-title":"Evaluation of the cardiotoxicity of evodiamine in vitro and in vivo","volume":"22","author":"Yang","year":"2017","journal-title":"Molecules"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/v4102031","article-title":"Pathogenesis of Lassa fever","volume":"4","author":"Yun","year":"2012","journal-title":"Viruses"},{"key":"B66","doi-asserted-by":"publisher","first-page":"9828","DOI":"10.1021\/acs.jmedchem.0c00983","article-title":"Discovery of evodiamine derivatives as highly selective PDE5 inhibitors targeting a unique allosteric pocket","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/ijms19051527","article-title":"Pharmacological basis for the use of evodiamine in Alzheimer's disease: antioxidation and antiapoptosis","volume":"19","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2022.12704","article-title":"Protection against ulcerative colitis and colorectal cancer by evodiamine via anti-inflammatory effects","volume":"25","author":"Zhang","year":"2022","journal-title":"Mol. Med. Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"27411","DOI":"10.3390\/ijms161126031","article-title":"Evodiamine induces apoptosis and inhibits migration of HCT-116 human colorectal cancer cells","volume":"16","author":"Zhao","year":"2015","journal-title":"Int. J. Mol. Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1007\/s13277-015-3174-z","article-title":"Apoptosis of human non-small-cell lung cancer A549 cells triggered by evodiamine through MTDH-dependent signaling pathway","volume":"36","author":"Zou","year":"2015","journal-title":"Tumor. Biol"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1206872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T06:26:46Z","timestamp":1689056806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1206872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":70,"alternative-id":["10.3389\/fmicb.2023.1206872"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1206872","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"article-number":"1206872"}}